EGRP News Flash - April 10, 2008
NIH Seeks Info on Pharmacogenomics by April 20th
We thought you might be interested in an opportunity to respond to a Request for Information (RFI) on challenges and barriers to pharmacogenomics research. The request is from the Trans-NIH Pharmacogenomics Working Group. The RFI is in the form of an on-line series of questions intended to reveal gaps and highlight opportunities in pharmacogenomics, and to aid in identifying specific, achievable goals that will advance and transform the field overall. NIH wants to consider research needs from discovery-based efforts to validation and applied research, in order to accelerate the translation of pharmacogenomics discoveries into the clinical realm.
NIH is interested in responses that suggest transformative ideas and approaches. The best ideas will have great potential to dramatically affect how biomedical research is conducted over the next decade, yet will be concrete and achievable tasks. Moreover, NIH wants to leverage existing research mechanisms and resources. Ideas for enabling research efforts of interest would be those challenges to pharmacogenomics that: (1) are activities that no other entity is likely to be able to successfully conduct, (2) will generate knowledge that can be made publicly accessible, and (3) are of clear benefit to public health.
Responses must be submitted electronically and will be accepted through April 30, 2008.
Contact: Rochelle M. Long, Ph.D., Chief, Pharmacology & Physiological Sciences Branch; Pharmacology, Physiology, & Biological Chemistry Division, National Institute of General Medical Sciences (NIGMS), e-mail: Rochelle.email@example.com.
Access the NIH Guide for Grants and Contracts for details: NOT-GM-08-125.